Articles with public access mandates - Timothy WeltyLearn more
Not available anywhere: 1
Generic-to-generic lamotrigine switches in people with epilepsy: the randomised controlled EQUIGEN trial
MD Privitera, TE Welty, BE Gidal, FJ Diaz, R Krebill, JP Szaflarski, ...
The Lancet Neurology 15 (4), 365-372, 2016
Mandates: US National Institutes of Health
Available somewhere: 4
Treatment of refractory convulsive status epilepticus: a comprehensive review by the American Epilepsy Society Treatments Committee
DG Vossler, JL Bainbridge, JG Boggs, EJ Novotny, T Loddenkemper, ...
Epilepsy Currents 20 (5), 245-264, 2020
Mandates: US Department of Defense, US National Institutes of Health, US Department of …
The essential research curriculum for doctor of pharmacy degree programs
MW Lee, PG Clay, WK Kennedy, MJ Kennedy, NM Sifontis, D Simonson, ...
Pharmacotherapy 30 (9), 966, 2010
Mandates: US National Institutes of Health
FDA safety warning on the cardiac effects of lamotrigine: An advisory from the Ad Hoc ILAE/AES Task Force
JA French, E Perucca, JW Sander, L Bergfeldt, M Baulac, DS Auerbach, ...
Epilepsy currents 21 (3), 150-153, 2021
Mandates: US National Science Foundation, US National Institutes of Health, Canadian …
Recommendations for treatment strategies in people with epilepsy during times of shortage of antiseizure medications
AA Asadi-Pooya, AA Patel, E Trinka, M Mazurkiewicz-Beldzinska, ...
Epileptic Disorders, 751-764, 2022
Mandates: US National Institutes of Health, Austrian Science Fund, UK Engineering and …
Publication and funding information is determined automatically by a computer program